Aller au contenu principal
Retour à l'annuaire
Rhumatologue

Docteur Inès MONINOT

📍 Saint-Martin-d'Uriage (38)HospitalierRPPS 10107127689

✨ Profil synthétique

IA · 01/05/2026

Le Docteur Inès MONINOT est un rhumatologue hospitalier à Saint-Martin-d'Uriage. Ses publications sur PubMed couvrent divers aspects de la rhumatologie, notamment le lupus, les essais cliniques et la pédiatrie. Elle a également contribué à des revues générales et à des études de cas dans le domaine.

Expertises présumées

  • Lupus
  • Rhumatologie pédiatrique
  • Essais cliniques
  • Recherche en vie réelle (RWE)
  • Études de cas en rhumatologie
  • Revue de littérature médicale

Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.

Diplômes

🎓 DES & spécialité ordinale

  • DES Rhumatologie
  • Rhumatologie (SM)

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Localisation

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieu de consultation

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

  • 1
    Deferred Cord Clamping With High Oxygen in Extremely Preterm Infants: A Randomized Clinical Trial

    JAMA pediatrics · 2025

    📚 15 citations🎯 RCR 6.63🩺 Clinique🔓 Open Access
    Lire l'abstract Crossref ↓

    Importance Deferred cord clamping (DCC) with high oxygen may reduce early hypoxia in preterm newborns. However, the safety and efficacy of this procedure has never been studied. Objective To determine whether providing 100% oxygen by face mask during the window of DCC in preterm infants reduces hypoxemia compared with 30% oxygen without hyperoxemia due to the continued mixing with umbilical venous blood. Design, Setting, and Participants This double-blinded randomized clinical trial took place from November 2021 to October 2024 at 2 universities and 1 private medical center in California. Participants included 140 preterm infants (born at 22 to 28 weeks’ gestation). These data were analyzed from November 2024 to May 2025. Interventions During DCC, infants received continuous positive airway pressure or positive pressure ventilation via face mask and were randomized to either 30% (low oxygen group) or 100% (high oxygen group) using a concealed blender. After the umbilical cord was clamped and cut, each infant was resuscitated per contemporary guidelines (30% oxygen and titration based on saturation of peripheral oxygen). Main Outcome The primary outcome was the number of infants who achieve peripheral oxygen saturations of 80% by 5 minutes of life. Results There were 140 infants randomized (mean gestational age, 26 weeks; 69 female [49%] and 71 male [51%]). In the low oxygen group, 28 of 72 infants (39%) achieved a peripheral oxygen saturation of 80% by 5 minutes compared with 47 of 68 infants (69%) in the high oxygen group (adjusted odds ratio, 3.74; 95% CI, 1.80-7.79; P < .001). The absolute risk difference between the 2 groups was 0.3 (95% CI, 0.26-0.35), indicating that the high oxygen group had a 30% lower risk of experiencing hypoxemia 5 minutes after birth. Maximum median fraction of inspired oxygen during resuscitation after DCC, umbilical arterial partial pressure of oxygen in arterial blood, severe intraventricular hemorrhage, and death before 40 weeks’ postmenstrual age were not different between groups. Conclusion and Relevance In this study, 100% oxygen during DCC reduced early hypoxemia without increased morbidity. A large randomized clinical trial is needed to determine if 100% oxygen during DCC improves survival and reduces longer-term morbidities in extremely preterm infants. Trial Registration ClinicalTrials.gov Identifier: NCT04413097

  • 2
    Association between gut microbiota and pediatric obesity: A systematic review

    Nutrition (Burbank, Los Angeles County, Calif.) · 2025

    📚 8 citations🎯 RCR 3.45🔓 Open Access
  • 3
    Risk of chronic kidney disease in 260 patients with lupus nephritis: analysis of a nationwide multicentre cohort with up to 35 years of follow-up

    Rheumatology (Oxford, England) · 2025

    📚 7 citations🎯 RCR 2.98🩺 Clinique🔓 Open Access📄 PDF gratuit ↗
    Lire l'abstract Crossref ↓

    Abstract Objectives To compare proliferative (PLN) and membranous (MLN) lupus nephritis (LN) regarding clinical and laboratory presentation and long-term outcomes, and to investigate predictors of progression to chronic kidney disease (CKD). Methods Multicentre observational study, with retrospective analysis of a prospective cohort, using data from the Rheumatic Diseases Portuguese Registry – Reuma.pt. Patients with biopsy-proven PLN, MLN and mixed LN were included. Cox regression survival analysis was used to investigate predictors of CKD. Results A total of 260 patients were included. Median follow-up was 8 years (IQR 11; minimum 1, maximum 35 years). MLN patients presented with significantly lower serum creatinine [0.70 (IQR 0.20; minimum 0.50, maximum 1.30) mg/dl vs 0.80 (IQR 0.31; minimum 0.26, maximum 2.60) in PLN, P = 0.003]. Proteinuria levels did not differ between groups (P = 0.641). Levels of complement were reduced in PLN but nearly normal in MLN patients, and there were fewer patients with positive anti-dsDNA antibodies in the MLN group (P < 0.001). One year after the beginning of treatment, 62% of the patients achieved EULAR/ERA-EDTA complete response, with a further 5% achieving partial response. Patients with lower proteinuria at diagnosis were more likely to achieve a complete renal response at one year; however, proteinuria at diagnosis or at one year did not predict long-term CKD. Estimated glomerular filtration rate (eGFR) ≤75 mL/min/1.73 m2 at one year was the strongest predictor of progression to CKD (HR 23 [95% CI 8–62], P < 0.001). Other possible predictors included the use of azathioprine for induction of remission, older age at diagnosis and male sex. Conclusion Proteinuria levels did not predict LN histologic class in our cohort. eGFR cutoff of 75 mL/min/1.73 m2 after one year of treatment was strongly predictive of progression to CKD.

Publications scientifiques (50) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal21

Lupus8

Case report / série5

Essai clinique5

Pédiatrie3

Revue générale3

Vraie vie / RWE3

IA en rhumatologie2

Microbiote2

Pharmacovigilance2

Biothérapies non-anti-TNF1

Corticothérapie1

Économie santé1

Épidémiologie & registres1

Qualité de vie / PROMs1

Revue / méta-analyse1

Santé mentale / fatigue1

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.